Case series: does a combination of anti-tnf antibodies and transient ileal fecal stream diversion in severe Crohn's colitis with perianal fistula prevent definitive stoma?

Am J Gastroenterol. 2013 Oct;108(10):1666-8. doi: 10.1038/ajg.2013.188.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Combined Modality Therapy
  • Crohn Disease / complications
  • Crohn Disease / therapy*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Ileostomy / methods*
  • Infliximab
  • Male
  • Middle Aged
  • Rectal Fistula / etiology
  • Rectal Fistula / therapy
  • Rectovaginal Fistula / etiology
  • Rectovaginal Fistula / therapy
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab